Keyphrases
B Cells
100%
Multiple Myeloma
100%
Plasma Cells
100%
Myeloma
100%
Lymphopoiesis
100%
Myeloid Differentiation Factor 88 (MyD88)
75%
BCL6
50%
C-X-C Chemokine Receptor Type 4 (CXCR4)
50%
Nanog
50%
C-Myc
50%
Cluster of Differentiation 47 (CD47)
50%
Sex-determining Region Y-box 2 (SOX2)
50%
Notch1
50%
IFN Regulatory Factor
50%
SET Domain
50%
CD117
50%
CyTOF
50%
CD200
50%
Clinical Outcomes
25%
Cell Markers
25%
Overexpression
25%
Transcription Factor
25%
B-cell Lymphoma 2 (Bcl-2)
25%
Hematopoietic Stem Cells
25%
Stem Cell Markers
25%
Molecular Profiling
25%
Disease Prognosis
25%
Cluster of Differentiation 44 (CD44)
25%
Cell Wall Proteins
25%
Receptor 2
25%
Mass Cytometry
25%
CD81
25%
CD28
25%
Cell Subsets
25%
Plasmablast
25%
Stemness
25%
Premalignant Condition
25%
CD56
25%
Transcription Factor E3 (TFE3)
25%
Nestin
25%
B Cell Development
25%
Retinoic Acid Receptor
25%
CD52
25%
Subclonal
25%
Smoldering multiple Myeloma
25%
Monoclonal Gammopathy of Undetermined Significance
25%
Disease Heterogeneity
25%
B Cell Signaling
25%
Clonal Plasma Cells
25%
Octamer Transcription Factor 1
25%
Neuroepithelial Stem Cells
25%
CD319
25%
Medicine and Dentistry
B Cell
100%
Lymphopoiesis
100%
Plasma Cell
100%
Myeloma
100%
Calcium Ion
80%
Multiple Myeloma
80%
B-Cell Lymphoma
40%
Notch
40%
Synapsin I
40%
Oncogene C Myc
40%
Disease
20%
Upregulation
20%
Stem Cell
20%
Hematopoietic Stem Cell
20%
Myeloid Differentiation
20%
Cell Marker
20%
Mass Cytometry
20%
Molecular Profiling
20%
Cell Protein
20%
Precancerous Condition
20%
B Cell Development
20%
Monoclonal Gammopathy of Undetermined Significance
20%
Smouldering Myeloma
20%
B Cell Signaling
20%
Nestin
20%
Retinoic Acid Receptor
20%
Octamer Transcription Factor 4
20%
Plasmablast
20%
Transcription Factor II
20%
Immunology and Microbiology
B Cell
100%
Plasma Cell
100%
Lymphopoiesis
100%
Multiple Myeloma
80%
CXCR4
40%
Notch
40%
Oncogene C Myc
40%
CD47
40%
CD117
40%
CD200
40%
MYD88
40%
Upregulation
20%
Bcl-2
20%
Stem Cell
20%
Myeloid Differentiation
20%
Cell Marker
20%
Hematopoietic Stem Cell
20%
Mass Cytometry
20%
CD81
20%
CD28
20%
CD44
20%
Plasmablast
20%
B Cell Development
20%
Monoclonal Immunoglobulinemia
20%
Smoldering Multiple Myeloma
20%
Octamer Transcription Factor 4
20%
B Cell Signaling
20%
Transcription Factor II
20%